George Jean
Insider CIK 1291804 · PTLA Director · XLRN Director · ZLTQ Director, 10% owner · CATB Director · CALA Director, 10% owner · CYT Director · SI · ALXO 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| SI SHOULDER INNOVATIONS, INC. | C Conversion deriv | 2025-08-01 | 2025-08-05 | 9,950,208 | — | $0 | 0 | SEC↗ |
| SI SHOULDER INNOVATIONS, INC. | C Conversion deriv | 2025-08-01 | 2025-08-05 | 20,930,233 | — | $0 | 0 | SEC↗ |
| SI SHOULDER INNOVATIONS, INC. | P Buy | 2025-08-01 | 2025-08-05 | 266,666 | $15.00 | $4.00M | 1,885,136 | SEC↗ |
| SI SHOULDER INNOVATIONS, INC. | C Conversion | 2025-08-01 | 2025-08-05 | 1,618,470 | — | $0 | 1,618,470 | SEC↗ |
| CYT Cyteir Therapeutics, Inc. | M Exercise deriv | 2024-02-14 | 2024-02-16 | 14,150 | — | $0 | 0 | SEC↗ |
| CYT Cyteir Therapeutics, Inc. | M Exercise | 2024-02-14 | 2024-02-16 | 14,150 | $1.69 | $23.9K | 14,150 | SEC↗ |
| CYT Cyteir Therapeutics, Inc. | A Award deriv | 2023-02-03 | 2023-02-07 | 14,150 | — | $0 | 14,150 | SEC↗ |
| CYT Cyteir Therapeutics, Inc. | A Award deriv | 2022-02-22 | 2022-02-24 | 14,150 | — | $0 | 14,150 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | S Sale | 2021-12-13 | 2021-12-15 | 2,196 | $28.37 | $62.3K | 2,099,095 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | S Sale | 2021-12-13 | 2021-12-15 | 299 | $28.37 | $8.5K | 286,197 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | S Sale | 2021-12-13 | 2021-12-15 | 1,329 | $29.60 | $39.3K | 2,097,766 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | S Sale | 2021-12-13 | 2021-12-15 | 60 | $30.23 | $1.8K | 285,956 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | S Sale | 2021-12-13 | 2021-12-15 | 1,627 | $25.29 | $41.1K | 290,131 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | S Sale | 2021-12-13 | 2021-12-15 | 440 | $30.23 | $13.3K | 2,097,326 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | S Sale | 2021-12-13 | 2021-12-15 | 1,296 | $27.49 | $35.6K | 286,496 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | S Sale | 2021-12-13 | 2021-12-15 | 9,509 | $27.49 | $261.4K | 2,101,291 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | S Sale | 2021-12-13 | 2021-12-15 | 2,339 | $26.48 | $61.9K | 287,792 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | S Sale | 2021-12-13 | 2021-12-15 | 17,169 | $26.48 | $454.6K | 2,110,800 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | S Sale | 2021-12-13 | 2021-12-15 | 181 | $29.60 | $5.4K | 286,016 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | S Sale | 2021-12-13 | 2021-12-15 | 11,945 | $25.29 | $302.1K | 2,127,969 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | S Sale | 2021-12-10 | 2021-12-10 | 12 | $32.16 | $386 | 291,758 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | S Sale | 2021-12-10 | 2021-12-10 | 88 | $32.16 | $2.8K | 2,139,914 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | S Sale | 2021-12-10 | 2021-12-10 | 2,172 | $31.55 | $68.5K | 291,770 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | S Sale | 2021-12-10 | 2021-12-10 | 15,942 | $31.55 | $503.0K | 2,140,002 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | S Sale | 2021-12-10 | 2021-12-10 | 967 | $30.77 | $29.8K | 293,942 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | S Sale | 2021-12-10 | 2021-12-10 | 7,093 | $30.77 | $218.3K | 2,155,944 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | S Sale | 2021-12-09 | 2021-12-10 | 1,911 | $32.73 | $62.5K | 294,909 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | S Sale | 2021-12-09 | 2021-12-10 | 14,028 | $32.73 | $459.1K | 2,163,037 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | S Sale | 2021-12-09 | 2021-12-10 | 5,751 | $32.06 | $184.4K | 296,820 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | S Sale | 2021-12-09 | 2021-12-10 | 42,203 | $32.06 | $1.35M | 2,177,065 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | S Sale | 2021-12-09 | 2021-12-10 | 1,560 | $31.08 | $48.5K | 302,571 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | S Sale | 2021-12-09 | 2021-12-10 | 11,452 | $31.08 | $355.9K | 2,219,268 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | S Sale | 2021-12-08 | 2021-12-10 | 35,836 | $33.23 | $1.19M | 2,232,251 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | S Sale | 2021-12-08 | 2021-12-10 | 1,531 | $33.80 | $51.7K | 2,230,720 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | S Sale | 2021-12-08 | 2021-12-10 | 4,883 | $33.23 | $162.3K | 304,339 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | S Sale | 2021-12-08 | 2021-12-10 | 208 | $33.80 | $7.0K | 304,131 | SEC↗ |
| CYT Cyteir Therapeutics, Inc. | C Conversion deriv | 2021-06-22 | 2021-06-24 | 832,026 | — | $0 | 0 | SEC↗ |
| CYT Cyteir Therapeutics, Inc. | C Conversion deriv | 2021-06-22 | 2021-06-24 | 7,500,000 | — | $0 | 0 | SEC↗ |
| CYT Cyteir Therapeutics, Inc. | C Conversion | 2021-06-22 | 2021-06-24 | 2,444,268 | — | $0 | 2,444,268 | SEC↗ |
| CALA Calithera Biosciences, Inc | A Award deriv | 2021-06-11 | 2021-06-14 | 20,000 | — | $0 | 20,000 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | C Conversion deriv | 2020-07-21 | 2020-07-22 | 59,998 | — | $0 | 0 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | C Conversion deriv | 2020-07-21 | 2020-07-22 | 39,758 | — | $0 | 0 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | C Conversion deriv | 2020-07-21 | 2020-07-22 | 683,523 | — | $0 | 0 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | C Conversion deriv | 2020-07-21 | 2020-07-22 | 222,752 | — | $0 | 0 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | C Conversion deriv | 2020-07-21 | 2020-07-22 | 1,633,743 | — | $0 | 0 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | C Conversion deriv | 2020-07-21 | 2020-07-22 | 38,660 | — | $0 | 0 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | C Conversion deriv | 2020-07-21 | 2020-07-22 | 137,286 | — | $0 | 0 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | C Conversion deriv | 2020-07-21 | 2020-07-22 | 664,660 | — | $0 | 0 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | C Conversion deriv | 2020-07-21 | 2020-07-22 | 18,705 | — | $0 | 0 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | C Conversion deriv | 2020-07-21 | 2020-07-22 | 11,110 | — | $0 | 0 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | C Conversion deriv | 2020-07-21 | 2020-07-22 | 150,801 | — | $0 | 0 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | C Conversion deriv | 2020-07-21 | 2020-07-22 | 8,175 | — | $0 | 0 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | C Conversion | 2020-07-21 | 2020-07-22 | 1,498,984 | — | $0 | 2,023,469 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | P Buy | 2020-07-21 | 2020-07-22 | 378,000 | $19.00 | $7.18M | 378,000 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | C Conversion | 2020-07-21 | 2020-07-22 | 249,632 | — | $0 | 309,222 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | P Buy | 2020-07-21 | 2020-07-22 | 22,000 | $19.00 | $418.0K | 22,000 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | C Conversion | 2020-07-21 | 2020-07-22 | 111,528 | — | $0 | 120,212 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | C Conversion | 2020-07-21 | 2020-07-22 | 1,831,027 | — | $0 | 2,268,087 | SEC↗ |
| CALA Calithera Biosciences, Inc | A Award deriv | 2020-06-09 | 2020-06-11 | 20,000 | — | $0 | 20,000 | SEC↗ |
| XLRN ACCELERON PHARMA INC | A Award deriv | 2020-01-22 | 2020-01-24 | 8,185 | — | $0 | 8,185 | SEC↗ |
| XLRN ACCELERON PHARMA INC | A Award | 2020-01-22 | 2020-01-24 | 1,377 | — | $0 | 5,127 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2019-06-28 | 2019-06-28 | 11,812 | $41.17 | $486.3K | 0 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2019-06-26 | 2019-06-28 | 10,000 | — | $0 | 0 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2019-06-26 | 2019-06-28 | 7,500 | — | $0 | 0 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2019-06-26 | 2019-06-28 | 20,000 | — | $0 | 0 | SEC↗ |
| XLRN ACCELERON PHARMA INC | J Other | 2019-06-26 | 2019-06-28 | 11,812 | — | $0 | 11,812 | SEC↗ |
| XLRN ACCELERON PHARMA INC | J Other | 2019-06-26 | 2019-06-28 | 11,812 | — | $0 | 3,750 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2019-06-26 | 2019-06-28 | 25,688 | $39.16 | $1.01M | 15,562 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2019-06-26 | 2019-06-28 | 7,500 | $30.17 | $226.3K | 41,250 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2019-06-26 | 2019-06-28 | 10,000 | $27.97 | $279.7K | 33,750 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2019-06-26 | 2019-06-28 | 20,000 | $24.11 | $482.2K | 23,750 | SEC↗ |
| CALA Calithera Biosciences, Inc | A Award deriv | 2019-05-30 | 2019-06-03 | 11,000 | — | $0 | 11,000 | SEC↗ |
| XLRN ACCELERON PHARMA INC | A Award deriv | 2019-01-25 | 2019-01-29 | 7,500 | — | $0 | 7,500 | SEC↗ |
| XLRN ACCELERON PHARMA INC | A Award | 2019-01-25 | 2019-01-29 | 1,250 | — | $0 | 3,750 | SEC↗ |
| CATB CATABASIS PHARMACEUTICALS | A Award deriv | 2018-06-07 | 2018-06-07 | 14,000 | — | $0 | 14,000 | SEC↗ |
| CALA Calithera Biosciences, Inc | A Award deriv | 2018-05-31 | 2018-06-04 | 11,000 | — | $0 | 11,000 | SEC↗ |
| XLRN ACCELERON PHARMA INC | A Award deriv | 2018-03-01 | 2018-03-05 | 7,500 | — | $0 | 7,500 | SEC↗ |
| XLRN ACCELERON PHARMA INC | A Award | 2018-03-01 | 2018-03-05 | 1,250 | — | $0 | 2,500 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2017-12-15 | 2017-12-18 | 105,122 | $35.73 | $3.76M | 0 | SEC↗ |
| CATB CATABASIS PHARMACEUTICALS | A Award deriv | 2017-07-27 | 2017-07-28 | 6,500 | — | $0 | 6,500 | SEC↗ |
| CALA Calithera Biosciences, Inc | A Award deriv | 2017-06-09 | 2017-06-13 | 11,000 | — | $0 | 11,000 | SEC↗ |
| XLRN ACCELERON PHARMA INC | A Award deriv | 2017-03-02 | 2017-03-14 | 7,500 | — | $0 | 7,500 | SEC↗ |
| XLRN ACCELERON PHARMA INC | A Award | 2017-03-02 | 2017-03-14 | 1,250 | — | $0 | 1,250 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2016-12-07 | 2016-12-19 | 127,122 | — | $0 | 0 | SEC↗ |
| XLRN ACCELERON PHARMA INC | F Tax w/h | 2016-12-07 | 2016-12-19 | 22,000 | $33.98 | $747.6K | 105,122 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2016-12-07 | 2016-12-19 | 127,122 | $5.88 | $747.5K | 127,122 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2016-11-17 | 2016-11-18 | 379,464 | $38.05 | $14.44M | 0 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2016-11-17 | 2016-11-18 | 41,112 | $39.13 | $1.61M | 379,464 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2016-11-16 | 2016-11-18 | 32,929 | $41.39 | $1.36M | 420,576 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2016-09-30 | 2016-10-04 | 857,145 | $35.50 | $30.43M | 453,505 | SEC↗ |
| CATB CATABASIS PHARMACEUTICALS | A Award deriv | 2016-08-03 | 2016-08-05 | 6,500 | — | $0 | 6,500 | SEC↗ |
| CALA Calithera Biosciences, Inc | A Award deriv | 2016-06-14 | 2016-06-16 | 11,000 | — | $0 | 11,000 | SEC↗ |
| XLRN ACCELERON PHARMA INC | A Award deriv | 2016-03-03 | 2016-03-07 | 10,000 | — | $0 | 10,000 | SEC↗ |
| ZLTQ Zeltiq Aesthetics Inc | A Award | 2015-07-22 | 2015-07-23 | 790 | — | $0 | 5,786 | SEC↗ |
| CATB CATABASIS PHARMACEUTICALS | C Conversion deriv | 2015-06-30 | 2015-06-30 | 8,666,667 | — | $0 | 0 | SEC↗ |
| CATB CATABASIS PHARMACEUTICALS | A Award deriv | 2015-06-30 | 2015-06-30 | 11,094 | — | $0 | 11,094 | SEC↗ |
| CATB CATABASIS PHARMACEUTICALS | C Conversion deriv | 2015-06-30 | 2015-06-30 | 1,006,712 | — | $0 | 0 | SEC↗ |
| CATB CATABASIS PHARMACEUTICALS | C Conversion deriv | 2015-06-30 | 2015-06-30 | 7,388,491 | — | $0 | 0 | SEC↗ |
| CATB CATABASIS PHARMACEUTICALS | C Conversion deriv | 2015-06-30 | 2015-06-30 | 3,910,392 | — | $0 | 0 | SEC↗ |
| CATB CATABASIS PHARMACEUTICALS | C Conversion | 2015-06-30 | 2015-06-30 | 574,979 | — | $0 | 574,979 | SEC↗ |
| CATB CATABASIS PHARMACEUTICALS | C Conversion | 2015-06-30 | 2015-06-30 | 304,309 | — | $0 | 978,755 | SEC↗ |
| CATB CATABASIS PHARMACEUTICALS | C Conversion | 2015-06-30 | 2015-06-30 | 78,342 | — | $0 | 78,342 | SEC↗ |
| CATB CATABASIS PHARMACEUTICALS | P Buy | 2015-06-30 | 2015-06-30 | 155,188 | $12.00 | $1.86M | 1,133,943 | SEC↗ |
| CATB CATABASIS PHARMACEUTICALS | P Buy | 2015-06-30 | 2015-06-30 | 91,166 | $12.00 | $1.09M | 666,145 | SEC↗ |
| CATB CATABASIS PHARMACEUTICALS | P Buy | 2015-06-30 | 2015-06-30 | 12,422 | $12.00 | $149.1K | 90,764 | SEC↗ |
| CATB CATABASIS PHARMACEUTICALS | C Conversion | 2015-06-30 | 2015-06-30 | 674,446 | — | $0 | 674,446 | SEC↗ |
| ZLTQ Zeltiq Aesthetics Inc | A Award | 2015-06-17 | 2015-06-19 | 4,996 | — | $0 | 4,996 | SEC↗ |
| CALA Calithera Biosciences, Inc | A Award deriv | 2015-06-09 | 2015-06-11 | 11,000 | — | $0 | 11,000 | SEC↗ |
| ZLTQ Zeltiq Aesthetics Inc | M Exercise deriv | 2015-01-15 | 2015-01-16 | 596 | — | $0 | 3,377 | SEC↗ |
| ZLTQ Zeltiq Aesthetics Inc | M Exercise deriv | 2015-01-15 | 2015-01-16 | 16,887 | — | $0 | 1,193 | SEC↗ |
| ZLTQ Zeltiq Aesthetics Inc | M Exercise | 2015-01-15 | 2015-01-16 | 596 | $5.06 | $3.0K | 17,483 | SEC↗ |
| ZLTQ Zeltiq Aesthetics Inc | S Sale | 2015-01-15 | 2015-01-16 | 17,483 | $29.26 | $511.6K | 0 | SEC↗ |
| ZLTQ Zeltiq Aesthetics Inc | M Exercise | 2015-01-15 | 2015-01-16 | 16,887 | $6.34 | $107.1K | 16,887 | SEC↗ |
| XLRN ACCELERON PHARMA INC | A Award deriv | 2015-01-08 | 2015-04-08 | 10,000 | — | $0 | 10,000 | SEC↗ |
| XLRN ACCELERON PHARMA INC | A Award deriv | 2015-01-08 | 2015-01-09 | 10,000 | — | $0 | 10,000 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2014-12-09 | 2014-12-10 | 8,778 | $40.11 | $352.1K | 1,310,650 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2014-12-08 | 2014-12-10 | 83,143 | $45.33 | $3.77M | 1,819,920 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2014-12-08 | 2014-12-10 | 5,486 | $46.02 | $252.5K | 1,814,434 | SEC↗ |
| ZLTQ Zeltiq Aesthetics Inc | M Exercise deriv | 2014-11-03 | 2014-11-04 | 11,920 | — | $0 | 18,080 | SEC↗ |
| ZLTQ Zeltiq Aesthetics Inc | M Exercise deriv | 2014-11-03 | 2014-11-04 | 5,563 | — | $0 | 3,973 | SEC↗ |
| ZLTQ Zeltiq Aesthetics Inc | M Exercise | 2014-11-03 | 2014-11-04 | 5,563 | $5.06 | $28.1K | 17,483 | SEC↗ |
| ZLTQ Zeltiq Aesthetics Inc | S Sale | 2014-11-03 | 2014-11-04 | 17,483 | $25.15 | $439.7K | 0 | SEC↗ |
| ZLTQ Zeltiq Aesthetics Inc | M Exercise | 2014-11-03 | 2014-11-04 | 11,920 | $6.34 | $75.6K | 11,920 | SEC↗ |
| CALA Calithera Biosciences, Inc | C Conversion deriv | 2014-10-07 | 2014-10-09 | 419,181 | — | $0 | 0 | SEC↗ |
| CALA Calithera Biosciences, Inc | C Conversion deriv | 2014-10-07 | 2014-10-09 | 634,195 | — | $0 | 0 | SEC↗ |
| CALA Calithera Biosciences, Inc | C Conversion deriv | 2014-10-07 | 2014-10-09 | 747,540 | — | $0 | 0 | SEC↗ |
| CALA Calithera Biosciences, Inc | C Conversion deriv | 2014-10-07 | 2014-10-09 | 9,166 | — | $0 | 0 | SEC↗ |
| CALA Calithera Biosciences, Inc | C Conversion | 2014-10-07 | 2014-10-09 | 1,810,082 | — | $0 | 1,810,082 | SEC↗ |
| CALA Calithera Biosciences, Inc | P Buy | 2014-10-07 | 2014-10-09 | 300,000 | $10.00 | $3.00M | 2,110,082 | SEC↗ |
| ZLTQ Zeltiq Aesthetics Inc | S Sale | 2014-07-31 | 2014-07-31 | 10,495 | $20.09 | $210.8K | 0 | SEC↗ |
| ZLTQ Zeltiq Aesthetics Inc | S Sale | 2014-07-31 | 2014-07-31 | 18,662 | $20.09 | $374.9K | 0 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2014-06-26 | 2014-06-27 | 10,320 | $35.01 | $361.3K | 1,903,063 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2014-06-25 | 2014-06-27 | 171 | $35.00 | $6.0K | 1,913,383 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2014-06-24 | 2014-06-24 | 10,402 | $35.03 | $364.4K | 1,913,554 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2014-06-23 | 2014-06-24 | 13,618 | $35.27 | $480.3K | 1,923,956 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2014-06-20 | 2014-06-24 | 1,457 | $35.02 | $51.0K | 1,937,574 | SEC↗ |
| ZLTQ Zeltiq Aesthetics Inc | A Award deriv | 2014-05-30 | 2014-06-03 | 30,000 | — | $0 | 30,000 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2014-05-05 | 2014-05-06 | 215,644 | $42.86 | $9.24M | 1,939,031 | SEC↗ |
| ZLTQ Zeltiq Aesthetics Inc | S Sale | 2014-01-21 | 2014-01-22 | 8,560 | $22.35 | $191.3K | 10,495 | SEC↗ |
| ZLTQ Zeltiq Aesthetics Inc | S Sale | 2014-01-21 | 2014-01-22 | 15,220 | $22.35 | $340.2K | 0 | SEC↗ |
| ZLTQ Zeltiq Aesthetics Inc | S Sale | 2014-01-17 | 2014-01-22 | 4,673 | $23.50 | $109.8K | 15,220 | SEC↗ |
| ZLTQ Zeltiq Aesthetics Inc | J Other | 2014-01-17 | 2014-01-22 | 36,210 | — | $0 | 33,969 | SEC↗ |
| ZLTQ Zeltiq Aesthetics Inc | J Other | 2014-01-17 | 2014-01-22 | 75,333 | — | $0 | 70,671 | SEC↗ |
| ZLTQ Zeltiq Aesthetics Inc | J Other | 2014-01-17 | 2014-01-22 | 1,877,270 | — | $0 | 1,761,086 | SEC↗ |
| ZLTQ Zeltiq Aesthetics Inc | J Other | 2014-01-17 | 2014-01-22 | 19,893 | — | $0 | 19,893 | SEC↗ |
| ZLTQ Zeltiq Aesthetics Inc | S Sale | 2014-01-17 | 2014-01-22 | 2,627 | $23.50 | $61.7K | 19,055 | SEC↗ |
| XLRN ACCELERON PHARMA INC | A Award deriv | 2013-12-05 | 2013-12-09 | 20,000 | — | $0 | 20,000 | SEC↗ |
| ZLTQ Zeltiq Aesthetics Inc | S Sale | 2013-11-14 | 2013-11-18 | 4,025,000 | $12.22 | $49.19M | 3,876,221 | SEC↗ |
| XLRN ACCELERON PHARMA INC | C Conversion deriv | 2013-09-24 | 2013-09-26 | 507,664 | — | $0 | 0 | SEC↗ |
| XLRN ACCELERON PHARMA INC | C Conversion deriv | 2013-09-24 | 2013-09-26 | 1,376,248 | — | $0 | 0 | SEC↗ |
| XLRN ACCELERON PHARMA INC | C Conversion deriv | 2013-09-24 | 2013-09-26 | 293,142 | — | $0 | 0 | SEC↗ |
| XLRN ACCELERON PHARMA INC | J Other deriv | 2013-09-24 | 2013-09-26 | 138,862 | — | $0 | 0 | SEC↗ |
| XLRN ACCELERON PHARMA INC | C Conversion deriv | 2013-09-24 | 2013-09-26 | 64,019 | — | $0 | 0 | SEC↗ |
| XLRN ACCELERON PHARMA INC | C Conversion deriv | 2013-09-24 | 2013-09-26 | 39,172 | — | $0 | 0 | SEC↗ |
| XLRN ACCELERON PHARMA INC | C Conversion | 2013-09-24 | 2013-09-26 | 1,376,248 | — | $0 | 1,385,980 | SEC↗ |
| XLRN ACCELERON PHARMA INC | C Conversion | 2013-09-24 | 2013-09-26 | 64,019 | — | $0 | 2,513,783 | SEC↗ |
| XLRN ACCELERON PHARMA INC | C Conversion | 2013-09-24 | 2013-09-26 | 507,664 | — | $0 | 1,893,644 | SEC↗ |
| XLRN ACCELERON PHARMA INC | C Conversion | 2013-09-24 | 2013-09-26 | 293,142 | — | $0 | 2,186,786 | SEC↗ |
| XLRN ACCELERON PHARMA INC | C Conversion | 2013-09-24 | 2013-09-26 | 39,172 | — | $0 | 2,225,958 | SEC↗ |
| XLRN ACCELERON PHARMA INC | J Other | 2013-09-24 | 2013-09-26 | 223,806 | — | $0 | 2,449,764 | SEC↗ |
| ZLTQ Zeltiq Aesthetics Inc | A Award deriv | 2013-06-19 | 2013-06-20 | 30,000 | — | $0 | 30,000 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | C Conversion deriv | 2013-05-28 | 2013-05-30 | 3,448 | — | $0 | 0 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | C Conversion deriv | 2013-05-28 | 2013-05-30 | 931,468 | — | $0 | 0 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | C Conversion deriv | 2013-05-28 | 2013-05-30 | 5,551 | — | $0 | 0 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | C Conversion deriv | 2013-05-28 | 2013-05-30 | 17,966 | — | $0 | 0 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | C Conversion deriv | 2013-05-28 | 2013-05-30 | 37,379 | — | $0 | 0 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | C Conversion deriv | 2013-05-28 | 2013-05-30 | 512 | — | $0 | 0 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | C Conversion deriv | 2013-05-28 | 2013-05-30 | 85,939 | — | $0 | 0 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | C Conversion deriv | 2013-05-28 | 2013-05-30 | 1,657 | — | $0 | 0 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | C Conversion deriv | 2013-05-28 | 2013-05-30 | 2,569 | — | $0 | 0 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | C Conversion deriv | 2013-05-28 | 2013-05-30 | 431,173 | — | $0 | 0 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | C Conversion deriv | 2013-05-28 | 2013-05-30 | 8,316 | — | $0 | 0 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | C Conversion deriv | 2013-05-28 | 2013-05-30 | 17,302 | — | $0 | 0 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | C Conversion | 2013-05-28 | 2013-05-30 | 1,448,580 | — | $0 | 1,448,580 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | C Conversion | 2013-05-28 | 2013-05-30 | 58,129 | — | $0 | 58,129 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | C Conversion | 2013-05-28 | 2013-05-30 | 27,939 | — | $0 | 27,939 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | C Conversion | 2013-05-28 | 2013-05-30 | 8,632 | — | $0 | 8,632 | SEC↗ |
| ZLTQ Zeltiq Aesthetics Inc | A Award deriv | 2012-06-14 | 2012-06-18 | 9,536 | — | $0 | 9,536 | SEC↗ |